Gilead Sciences, Inc. 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:51 pm Unchanged | 2023-12-31 | 13G | Tango Therapeutics, Inc. TNGX | GILEAD SCIENCES INC. GILD | 4,854,443 4.800% | 0 (Unchanged) | Filing |
| 2021-09-10 12:17 pm Purchase | 2021-08-10 | 13G | Tango Therapeutics, Inc. TNGX | GILEAD SCIENCES INC. GILD | 4,854,443 5.500% | 4,854,443 (New Position) | Filing |